← Open Payments lookup

ALEXIS GURECKI: Open Payments

NPI 1831329598 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,910 in 72 payments from 18 companies in 2025. Trend: 2023 $1,324 · 2024 $1,039 · 2025 $1,910

Food & beverage: $1,820Education: $90
CompanyPaymentsAmount
Janssen Biotech, Inc.7$308
Regeneron Healthcare Solutions, Inc.8$239
Ipsen Biopharmaceuticals, Inc4$193
Takeda Pharmaceuticals U.S.A., Inc.9$186
ABBVIE INC.9$182
QOL Medical, LLC6$150
Ardelyx, Inc.5$124
Optinose US, Inc.4$83
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$76
Genentech USA, Inc.3$71

Products named: TREMFYA, DUPIXENT, IQIRVO, ENTYVIO, Sucraid, IBSRELA, Xhance, XIFAXAN.

Industry payments across VA — which companies pay providers there.